HOME >> BIOLOGY >> NEWS
Lupus Research Institute awards $3 million in novel research grants to further new science in lupus

and activated macrophages of dendritic cells.

"By bringing new minds and new eyes to solving the perplexing challenges we face in lupus, the LRI is moving closer each day toward prevention, improved therapies and a cure for lupus," said William Paul, MD, chief of the Laboratory of Immunology of the National Institute of Allergy and Infectious Diseases at the NIH who serves as Chairman of the LRI Scientific Advisory Board.

Lupus affects 1-1.5 million Americans and is a leading cause of kidney disease, stroke and cardiovascular disease in young women. Currently available treatments are often toxic, and there hasn't been a new drug approved for lupus in 40 years. The Lupus Research Institute is leading the advancement of new science to prevent, treat and cure lupus. More information about the Lupus Research Institute is available at www.lupusresearchinstitute.org.


'"/>

Contact: Lydia Dorsky
ldorsky@lupusny.org
212-685-4118
Lupus Research Institute
16-Jun-2004


Page: 1 2 3 4 5 6

Related biology news :

1. Lupus study finds abnormal alpha-interferon secretion may lead to better therapies for immune-system disease
2. Key Peptides Found That Stop -- Even Reverse -- Kidney Disease In Lupus
3. Researchers determine genetic cause of Timothy syndrome
4. Researchers find color sensitive atomic switch in bacteria
5. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
6. Researchers identify protein promoting vascular tumor growth
7. Researchers devise potent new tools to curb ivory poaching
8. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
9. Researchers ID chlorophyll-regulating gene
10. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
11. Research suggests new avenue for stopping, preventing colon cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , ... fibrotic diseases, today announced that Dr. Stacie Canan has joined the company as ... previously served as Executive Director of Global Health at Bristol Myers Squibb (formerly ...
(Date:8/23/2020)... , ... August 21, 2020 , ... ... Corporation has been published and is now available on the company’s global ... diffraction—serves the X-ray analysis community, presenting current news and crystallographic research. , ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA ... , a Clinical Operations executive with expertise in clinical trial planning and feasibility, ... as an Expert Consultant. Throughout his career, Mr. Movahhed has helped design and ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 16, 2020 , ... After ... begins. The completion of a great surgery is only the beginning of a successful ... the research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , ... in 2020, despite many obstacles created as a result of COVID-19. As a ... its partnered medical practices and medical manufacturers by expanding access to device offerings, ...
(Date:6/28/2020)... ROCKY HILL, Conn. (PRWEB) , ... June 25, ... ... systems company formed to advance photodynamic therapy for treating cancer, today announced the ... Buffalo, New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights ...
Breaking Biology Technology:
Cached News: